首页 | 本学科首页   官方微博 | 高级检索  
检索        


Comparative safety study on severe anemia by simeprevir versus telaprevir‐based triple therapy for chronic hepatitis C
Authors:Eiichi Ogawa  Norihiro Furusyo  Eiji Kajiwara  Hideyuki Nomura  Akira Kawano  Kazuhiro Takahashi  Kazufumi Dohmen  Takeaki Satoh  Koichi Azuma  Makoto Nakamuta  Toshimasa Koyanagi  Kazuhiro Kotoh  Shinji Shimoda  Jun Hayashi  The Kyushu University Liver Disease Study Group
Institution:1. Department of General Internal Medicine, Kyushu University Hospital, Fukuoka, Japan;2. Department of Hepatology, Steel Memorial Yawata Hospital, Kitakyushu, Japan;3. The Center for Liver Disease, Shin‐Kokura Hospital, Kitakyushu, Japan;4. Department of Medicine, Kitakyushu Municipal Medical Center, Kitakyushu, Japan;5. Department of Medicine, Hamanomachi Hospital, Fukuoka, Japan;6. Department of Internal Medicine, Chihaya Hospital, Fukuoka, Japan;7. Center for Liver Disease, National Hospital Organization Kokura Medical Center, Kitakyushu, Japan;8. Department of Medicine, Kyushu Central Hospital, Fukuoka, Japan;9. Department of Gastroenterology, Kyushu Medical Center, National Hospital Organization, Fukuoka, Japan;10. Department of Medicine, Fukuoka City Hospital, Fukuoka, Japan;11. Department of Medicine and Bioregulatory Science, Kyushu University, Fukuoka, Japan;12. Department of Medicine and Biosystemic Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan;13. Kyushu General Internal Medicine Center, Haradoi Hospital, Fukuoka, Japan
Abstract:
Keywords:anemia  hepatitis C virus  inosine triphosphatase  ribavirin  simeprevir
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号